MEDICINE DETAILS
Ruzurgi
Active ingredient: Amifampridine
Neutral reference profile for an independent medicine-access consultancy enquiry about Ruzurgi (Amifampridine). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
No ready-made options were found for this medicine. You can type the details in the form.
Continue to the form→✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Ruzurgi used for?
The effectiveness of Ruzurgi (amifampridine) for the treatment of LEMS was established by a randomized, double-blind, placebo-controlled withdrawal study of 32 adult patients in which patients were taking Ruzurgi for at least three months prior to entering the study. The study compared patients continuing on Ruzurgi (amifampridine) to patients switched to placebo. Effectiveness was measured by the degree of change in a test that assessed the time it took the patient to rise from a chair, walk three meters, and return to the chair for three consecutive laps without pause. The patients that continued on Ruzurgi (amifampridine) experienced less impairment than those on placebo. Effectiveness was also measured with a self-assessment scale for LEMS-related weakness that evaluated the feeling of weakening or strengthening. The scores indicated greater perceived weakening in the patients switched to placebo.
Please refer to the full prescribing information below for comprehensive information about the safety and effectiveness of Ruzurgi (amifampridine) for the approved indication.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Ruzurgi identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
No ready-made option can be shown.
Do not guess a missing strength or pack; use the details on the prescription and medicine box.
OFFICIAL SOURCES
Check the Ruzurgi record at an official source.
Search for “Ruzurgi” or “Amifampridine”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Ruzurgi.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Ruzurgi
01What is Ruzurgi?＋
This directory record associates the brand name Ruzurgi with the active ingredient Amifampridine. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Ruzurgi strengths and packs are recorded?＋
No ready-made strength and pack option can currently be shown from the catalogue record. Do not guess missing details; use the prescription and medicine box.
03Who manufactures Ruzurgi?＋
No organisation name can currently be shown confidently from the catalogue record. Verify the manufacturer or marketing-authorisation holder on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Ruzurgi?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Ruzurgi, payment request, stock guarantee or binding offer.
06Can I buy Ruzurgi from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.